Literature DB >> 7051409

An in vivo model for studying platelet aggregation and disaggregation.

C P Page, W Paul, J Morley.   

Abstract

A simple minimally invasive technique has been developed for the continuous monitoring of 111-Indium labelled homologous platelets in the thoracic (C1) and abdominal (C2) regions of experimental animals. The effects of the aggregatory agents adenosine diphosphate (ADP), collagen and platelet activating factor (PAF) and the anti-aggregatory agent, prostacyclin (PGI2) have been studied in the guinea-pig. Administration of ADP, collagen or PAF produces an increase in counts in C1, a decrease in counts in C2, and hence an increase in the ratio C1/C2. The rise in C1/C2 is more protracted after collagen administration than after ADP or PAF. PGI2 (50-500 ng/kg) reduces the response to ADP. The present technique is both simple, reproducible and although the present experiments are in the presence of heparin, the technique remains functional in the presence of minimal heparin, thus making it a suitable method for studies of platelet function and the evaluation of anti-aggregatory agents in vivo.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7051409

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  18 in total

1.  Pharmacological modulation of the effects of N-formyl-L-methionyl-L-leucyl-L-phenylalanine in guinea-pigs: involvement of the arachidonic acid cascade.

Authors:  M A Boukili; M Bureau; V Lagente; J Lefort; A Lellouch-Tubiana; E Malanchère; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1986-10       Impact factor: 8.739

2.  Antigen induces leucopenia in non-immunised guinea-pigs injected with platelets from actively sensitized animals.

Authors:  M Pretolani; J Randon; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

3.  The involvement of platelet activating factor in endotoxin-induced pulmonary platelet recruitment in the guinea-pig.

Authors:  L Beijer; J Botting; P Crook; A O Oyekan; C P Page; R Rylander
Journal:  Br J Pharmacol       Date:  1987-12       Impact factor: 8.739

4.  Pharmacological differentiation by pertussis toxin of the in vivo acute responses to fMLP and PAF in guinea-pig lungs.

Authors:  C D Arreto; M F Bureau; A Imaizumi; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

5.  Vascular permeability induced by Paf-acether (platelet-activating factor) in the isolated perfused rat kidney.

Authors:  E Pirotzky; C Page; J Morley; J Bidault; J Benveniste
Journal:  Agents Actions       Date:  1985-03

6.  Pulmonary platelet kinetics in asthma.

Authors:  P W Ind; A M Peters; F Malik; J P Lavender; C T Dollery
Journal:  Thorax       Date:  1985-06       Impact factor: 9.139

7.  In vivo platelet aggregation in the rat: dependence on extracellular divalent cation and inhibition by nonsteroidal anti-inflammatory drugs.

Authors:  G Mallarkey; G M Smith
Journal:  Br J Pharmacol       Date:  1984-01       Impact factor: 8.739

8.  Kinetics of acetyl glyceryl ether phosphorylcholine (AGEPC)-induced acute lung alterations in the rabbit.

Authors:  L M McManus; R N Pinckard
Journal:  Am J Pathol       Date:  1985-10       Impact factor: 4.307

9.  Histamine and leukotriene-independent guinea-pig anaphylactic shock unaccounted for by Paf-acether.

Authors:  A Detsouli; J Lefort; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1985-04       Impact factor: 8.739

10.  Inflammatory actions of platelet activating factor (Pafacether) in guinea-pig skin.

Authors:  J Morley; C P Page; W Paul
Journal:  Br J Pharmacol       Date:  1983-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.